Patents by Inventor Torsten M. Madsen

Torsten M. Madsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING DISORDERS ASSOCIATED WITH ELEVATED LEVELS OF ANTIBODIES THAT INTERACT WITH THE NMDA RECEPTOR
    Publication number: 20220273629
    Abstract: Methods of treating a disorder associated with elevated NMDAR antibodies in a patient in need thereof are provided comprising, for example, administering to the patient an effective amount of a spiro-?-lactam compound.
    Type: Application
    Filed: July 30, 2020
    Publication date: September 1, 2022
    Inventors: Joseph R. Moskal, Roger A. Kroes, Torsten M. Madsen
  • METHODS OF TREATING COGNITIVE IMPAIRMENT ASSOCIATED WITH NEURODEGENERATIVE DISEASE
    Publication number: 20210322393
    Abstract: Provided herein are methods of treating cognitive impairment associated with neurodegenerative disease in a patient by administering to the patient an effective amount of the Compound, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: December 3, 2020
    Publication date: October 21, 2021
    Inventors: Torsten M. Madsen, Ferenc Martenyi
  • METHODS OF TREATING FIBROMYALGIA
    Publication number: 20210308101
    Abstract: Provided herein are methods of treating fibromyalgia, in a patient by administering to the patient an effective amount of NYX-2925 or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: November 10, 2020
    Publication date: October 7, 2021
    Inventor: Torsten M. Madsen
  • METHODS OF TREATING PAINFUL DIABETIC PERIPHERAL NEUROPATHY
    Publication number: 20210139489
    Abstract: Provided herein are methods of treating painful diabetic peripheral neuropathy, such as advanced painful DPN, in a patient by administering to the patient an effective amount of NYX-2925 or a pharmaceutically acceptable salt thereof. Also provided are crystalline forms of 3-hydroxy-2-(5-isobutyryl-1-oxo-2,5-diazaspiro[3,4]octan-2-yl)butanamide.
    Type: Application
    Filed: November 10, 2020
    Publication date: May 13, 2021
    Inventors: Torsten M. Madsen, M. Amin Khan, Mohsen Arghavani, Phil Bauer, Eduardo Mar